FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2095994328> ?p ?o ?g. }

• W2095994328 endingPage "3733" @default.
• W2095994328 startingPage "3726" @default.
• W2095994328 abstract "ABSTRACT The mechanism underlying a dose-dependent, reversible increase in serum creatinine (SC) caused by the administration of PA-824, a novel nitroimidazo-oxazine, was evaluated in 47 healthy male and female volunteers. Subjects were administered either 800 or 1,000 mg PA-824 or matching placebo once daily for 8 days. The following renal function parameters were determined before and during dosing and after a 7-day washout: SC, glomerular filtration rate (GFR; measured as the iohexol clearance), effective renal plasma flow (ERPF; measured as the para-amino hippurate clearance), filtration fraction (FF), creatinine clearance (CrCl), extraglomerular creatinine excretion (EGCE; defined as CrCl minus GFR), blood urea nitrogen (BUN), and uric acid (UA) levels. Eight days' administration of 800 or 1,000 mg PA-824 was associated with increased SC and a trend toward decreased CrCl and EGCE. SC, CrCl, and EGCE values returned to normal/baseline within 1 week's washout. GFR, ERPF, FF, BUN, and UA values were similar across groups during treatment and washout. The reversible increase in SC observed in this and earlier trials of PA-824, thus, did not appear to be the result of a pathological effect on renal function (as measured by GFR, ERPF, FF, BUN, or UA). Pharmacokinetic analyses confirmed that PA-824 exposures were similar to those in previous healthy-volunteer clinical studies. That EGCE declined maximally when drug levels were highest suggests that PA-824 causes creatinine levels to rise by inhibiting renal tubular creatinine secretion. Such an effect, considered clinically benign, has been described for several marketed drugs." @default.
• W2095994328 created "2016-06-24" @default.
• W2095994328 creator A5004367252 @default.
• W2095994328 creator A5008456116 @default.
• W2095994328 creator A5063431324 @default.
• W2095994328 creator A5065331569 @default.
• W2095994328 creator A5088216487 @default.
• W2095994328 date "2009-09-01" @default.
• W2095994328 modified "2023-09-27" @default.
• W2095994328 title "Assessment of the Effects of the Nitroimidazo-Oxazine PA-824 on Renal Function in Healthy Subjects" @default.
• W2095994328 cites W1971974715 @default.
• W2095994328 cites W1977671952 @default.
• W2095994328 cites W2030578796 @default.
• W2095994328 cites W2066661427 @default.
• W2095994328 cites W2073477977 @default.
• W2095994328 cites W2079928834 @default.
• W2095994328 cites W2133587820 @default.
• W2095994328 cites W2136871445 @default.
• W2095994328 cites W2140591070 @default.
• W2095994328 cites W2168240398 @default.
• W2095994328 cites W2180745593 @default.
• W2095994328 doi "https://doi.org/10.1128/aac.00112-09" @default.
• W2095994328 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2737878" @default.
• W2095994328 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19528286" @default.
• W2095994328 hasPublicationYear "2009" @default.
• W2095994328 type Work @default.
• W2095994328 sameAs 2095994328 @default.
• W2095994328 citedByCount "57" @default.
• W2095994328 countsByYear W20959943282012 @default.
• W2095994328 countsByYear W20959943282013 @default.
• W2095994328 countsByYear W20959943282014 @default.
• W2095994328 countsByYear W20959943282015 @default.
• W2095994328 countsByYear W20959943282018 @default.
• W2095994328 countsByYear W20959943282019 @default.
• W2095994328 countsByYear W20959943282020 @default.
• W2095994328 countsByYear W20959943282021 @default.
• W2095994328 countsByYear W20959943282022 @default.
• W2095994328 countsByYear W20959943282023 @default.
• W2095994328 crossrefType "journal-article" @default.
• W2095994328 hasAuthorship W2095994328A5004367252 @default.
• W2095994328 hasAuthorship W2095994328A5008456116 @default.
• W2095994328 hasAuthorship W2095994328A5063431324 @default.
• W2095994328 hasAuthorship W2095994328A5065331569 @default.
• W2095994328 hasAuthorship W2095994328A5088216487 @default.
• W2095994328 hasBestOaLocation W20959943282 @default.
• W2095994328 hasConcept C10146269 @default.
• W2095994328 hasConcept C112705442 @default.
• W2095994328 hasConcept C119584498 @default.
• W2095994328 hasConcept C126322002 @default.
• W2095994328 hasConcept C126894567 @default.
• W2095994328 hasConcept C134018914 @default.
• W2095994328 hasConcept C142225936 @default.
• W2095994328 hasConcept C159641895 @default.
• W2095994328 hasConcept C185592680 @default.
• W2095994328 hasConcept C21652263 @default.
• W2095994328 hasConcept C2776768635 @default.
• W2095994328 hasConcept C2778176769 @default.
• W2095994328 hasConcept C2779881121 @default.
• W2095994328 hasConcept C2780091579 @default.
• W2095994328 hasConcept C2780306776 @default.
• W2095994328 hasConcept C6557445 @default.
• W2095994328 hasConcept C71839028 @default.
• W2095994328 hasConcept C71924100 @default.
• W2095994328 hasConcept C86803240 @default.
• W2095994328 hasConceptScore W2095994328C10146269 @default.
• W2095994328 hasConceptScore W2095994328C112705442 @default.
• W2095994328 hasConceptScore W2095994328C119584498 @default.
• W2095994328 hasConceptScore W2095994328C126322002 @default.
• W2095994328 hasConceptScore W2095994328C126894567 @default.
• W2095994328 hasConceptScore W2095994328C134018914 @default.
• W2095994328 hasConceptScore W2095994328C142225936 @default.
• W2095994328 hasConceptScore W2095994328C159641895 @default.
• W2095994328 hasConceptScore W2095994328C185592680 @default.
• W2095994328 hasConceptScore W2095994328C21652263 @default.
• W2095994328 hasConceptScore W2095994328C2776768635 @default.
• W2095994328 hasConceptScore W2095994328C2778176769 @default.
• W2095994328 hasConceptScore W2095994328C2779881121 @default.
• W2095994328 hasConceptScore W2095994328C2780091579 @default.
• W2095994328 hasConceptScore W2095994328C2780306776 @default.
• W2095994328 hasConceptScore W2095994328C6557445 @default.
• W2095994328 hasConceptScore W2095994328C71839028 @default.
• W2095994328 hasConceptScore W2095994328C71924100 @default.
• W2095994328 hasConceptScore W2095994328C86803240 @default.
• W2095994328 hasIssue "9" @default.
• W2095994328 hasLocation W20959943281 @default.
• W2095994328 hasLocation W20959943282 @default.
• W2095994328 hasLocation W20959943283 @default.
• W2095994328 hasLocation W20959943284 @default.
• W2095994328 hasOpenAccess W2095994328 @default.
• W2095994328 hasPrimaryLocation W20959943281 @default.
• W2095994328 hasRelatedWork W1974831299 @default.
• W2095994328 hasRelatedWork W2067266504 @default.
• W2095994328 hasRelatedWork W2067778254 @default.
• W2095994328 hasRelatedWork W2090983615 @default.
• W2095994328 hasRelatedWork W2092844398 @default.
• W2095994328 hasRelatedWork W2095214324 @default.
• W2095994328 hasRelatedWork W2095994328 @default.
• W2095994328 hasRelatedWork W2413530128 @default.

• next